David H. Schnabel
Lawyers
![](/sites/default/files/styles/teaser_headshot/public/lawyer-images/30432_dschnab_0.jpg?itok=ziOh8HWx)
Filters
Precigen sale of Trans Ova Genetics to URUS
We are advising Precigen on the transaction
Brookfield Asset Management $750 million notes offering
The first-lien notes are due 2029
Bansk Group majority investment in amika and Eva NYC
We advised Bansk Group in the transaction
Brookfield $5 billion loan financing and $1.5 billion debt tender offers
We advised Brookfield Asset Management on the financings in connection with its acquisition of CDK Global
Brookfield $8.3 billion acquisition of CDK Global
We are advising Brookfield on the transaction
SatixFy $813 million combination with Endurance Acquisition
We are advising SatixFy on the transaction
BlueVoyant $250 million Series D funding
We are advising BlueVoyant on the transaction
Sallie Mae acquisition of Nitro College
We are advising Sallie Mae on the transaction
TPG $1 billion IPO
We are advising TPG as issuer
Convey Health Solutions acquisition of HealthSmart International
We are advising Convey Health Solutions on the transaction